vx 497 has been researched along with 4,5-di-O-caffeoylquinic acid in 1 studies
| Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (4,5-di-O-caffeoylquinic acid) | Trials (4,5-di-O-caffeoylquinic acid) | Recent Studies (post-2010) (4,5-di-O-caffeoylquinic acid) |
|---|---|---|---|---|---|
| 25 | 3 | 7 | 14 | 0 | 8 |
| Protein | Taxonomy | vx 497 (IC50) | 4,5-di-O-caffeoylquinic acid (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.1 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.3 | |
| Integrase | Human immunodeficiency virus 2 | 0.5 | |
| Integrase | Human immunodeficiency virus 1 | 0.6675 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for vx 497 and 4,5-di-O-caffeoylquinic acid
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |